Expert Profile

Dr. Konrade von Bremen, MD
Position(s) CEO of SWAN Isotopen AG

Dr. Konrade von Bremen, MD is an Associate Fellow within the Global Fellowship Initiative of the GCSP. Dr. Konrade von Bremen (MD) Is the CEO of SWAN Isotopen AG, a Swiss Radiopharmaceutical Company, located in Bern on the Campus of the Inselspital the University Hospital, Bern. She was instrumental from developing the concept to the establishment of the company in 2008 and to SWAN's successful positioning in this particular market.  

Konrade joined the GCSP activities by teaching negotiation courses in GCSP's executive education segment. Before engaging in the radiopharmaceutical field Konrade served several years as Associate Medical Director at CHUV, the University Hospital in Lausanne, Switzerland, followed by a 3 year commitment as Medical Director for Medtronic Europe. With her experience in both the public and private sector, she developed a particular experience in the field of collaboration between industry and academia. In addition, Konrade joined the Harvard Kennedy School of Government in 1998 for Executive Health Policy courses and was asked to lead working groups later for 3 years.

Konrade has a long term teaching experience in Health Care Management, as she was active at the Catholic University in Rome, the University of Lausanne and the University of Cassino, Italy, where she held the position of an Associate Professor for 4 years until 2009.

As of 2002, Konrade was is involved in EU research projects in particular in the Marie Curie actions program as a program leader. Since then she evaluated regularly medical research projects for the EU Commission.

One of her personal interests and commitments are in humanitarian medicine. She joined the "Hope Health Care Project" in Bosnia in 2002 and supports the Togo Child organization "Avenir enfance Togo" since 2000.

Konrade von Bremen obtained her medical diploma at the University of Siena Italy in 1991. She specialized in Internal Medicine in Lausanne, Switzerland in 1996 and obtained a Master in Health Economics and Management from the same University in 2000. She further obtained CAS from the University of St. Gallen in Global Negotiation, European Business Law and Finance, and a CAS in Management of Technology from the Ecole Poliytechnique Fédérale de Lausanne.